so it would seem MSB going with a belt and braces approach:
- prove the potency continuance to validate the efficacy of previous trial
- prove the efficacy AND potency of the current inventory in Adult trial
still not sure why they just didn't do the latter to begin with.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.25 |
Change
-0.160(6.64%) |
Mkt cap ! $3.084B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.35 | $2.25 | $5.865M | 2.543M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 97951 | $2.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.27 | 24022 | 12 |
View Market Depth
| Last trade - 10.17am 21/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |